Below you will find news and press releases from industry, government, and academia regarding product developments and medical/scientific research news.
Prasterone Shows Promise In Reducing Severity of Urinary Urge Incontinence
Because of a decrease in estrogen, menopause is often accompanied by multiple vaginal and urinary issues. To date, most treatment options focus on vulvar and vaginal atrophy, with fewer options available to treat urinary incontinence. A new study, however, suggests prasterone is effective in improving the severity of urinary urge incontinence. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). Read more.
Source: Newswise, July 27, 2022
Urinary Incontinence Poses Burden to Long-Term Care
The impact and management of urinary incontinence (UI) related to overactive bladder is a substantial burden to long-term care (LTC) residents and staff, according to a study published online July 1 in the Journal of Gerontological Nursing. Richard G. Stefanacci, D.O., from Thomas Jefferson University in Philadelphia, and colleagues assessed the impact of UI on residents, staff, care processes, and quality measures in LTC settings. The analysis included responses from directors of nursing who had worked for at least one year in a ≥100-bed facility. Read more.
Source: Health Day News, July 25, 2022
First Quality Introduces Size 8 Youth Diaper for More Inclusive Care
First Quality has launched Boundless™ by Cuties®, a size 8 youth diaper for children with special needs who have outgrown baby diapers, but who are not yet ready for adult incontinence products. Boundless youth diapers aim to provide Complete Care for All, so that every child can feel confident and protected. The first-of-its-kind youth diaper provides the same protection as a baby diaper but is designed to fit the frame of children who are 58 lbs. or more and managing incontinence issues. Read more.
Source: PRNewswire, July 20, 2022
What Has Stayed and What Disappeared In Benign Urology
“Any knowledge that doesn’t lead to new questions quickly dies out: it fails to maintain the temperature required for sustaining life,” said poet and Nobel Laureate Wislawa Szymborska. Looking back at the past 50 years, I recounted the achievements and yet-to-be-conquered goals. It is also prudent to think back to what ideas/concepts have withstood the test of time, in the quest for knowledge and the inherent desire to replace old with new. Read more.
Source: Urology Times, June 16, 2022
Ipsen Receives Positive Opinion In Europe for Dysport® In the Management of Urinary Incontinence In Adults With Neurogenic Detrusor Overactivity Due to Multiple Sclerosis or Spinal Cord Injury
Ipsen (Euronext: IPN; ADR: IPSEY) today announced that Dysport® (abobotulinumtoxinA) has received positive opinion in Europe for the management of urinary incontinence (UI) in adults with neurogenic detrusor overactivity (NDO) due to spinal cord injury (SCI) (traumatic or non-traumatic) or multiple sclerosis (MS), who are regularly performing clean intermittent catheterization (CIC). This positive opinion for Dysport® now permits individual European country Health Authorities to grant national approvals, according to their country regulations. In addition, Ipsen is also currently in the process of obtaining approvals in other countries outside the European Union. Read more.
Source: Globe Newswire, June 9, 2022
COVID-19 Infection Increases the Risk of New or Worsening OAB Symptoms
Patients with COVID-19 infection are at increased risk of developing new or worsening symptoms of overactive bladder (OAB), according to data presented at the American Urological Association’s annual meeting in 2022 in New Orleans, Louisiana. Ly Hoang Roberts, MD, of Oakland University, Royal Oak, Michigan, and colleagues noted that they were the first American group to identify de novo genitourinary symptoms, such as frequency, urgency, nocturia, and pain / pressure in people with previous COVID 19 infection. They called this condition COVID-19 associated cystitis (CAC). Read more.
Source: Community 99, May 15, 2022
First Quality Introduces MaxSorb+ Zone For Bladder Control Pads
First Quality Products, Inc. is launching a new technology for bladder control pads called MaxSorb+ Zone, providing enhanced rapid absorption to help keep skin dry all day and support skin health. Pads that use First Quality’s MaxSorb+ Zone absorb up to 50% faster compared to previous Prevail bladder control pads. Read more.
Source: Nonwovens Industry, April 28, 2022